Federal
Register Notices > Notice of
Application - 2006
>
Noramco Inc.
FR Doc E6-20341 [Federal Register: December 1, 2006 (Volume 71, Number 231)]
[Notices] [Page 69593] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01de06-113]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is
notice that on June 27, 2006, Noramco Inc., 1440 Olympic Drive, Athens, Georgia
30601, made application by letter to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of Oxymorphone (9652), a basic class of
controlled substance listed in schedule II.
The company plans to manufacture for in-house dosage form production and for
sales to other dosage form manufacturers. Any other such applicant and any
person who is presently registered with DEA to manufacture such a substance may
file comments or objections to the issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative/ODL; or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301;
and must be filed no later than January 30, 2007.
Dated: November 21, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-20341 Filed 11-30-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|